Top Institutions in Ophthalmology and Neurodegenerative Disease Research
Institutions leading in ophthalmology, neurodegeneration, and metabolic disease research have conducted clinical trials, observational studies, and preclinical models investigating the neuroprotective effects of systemic diabetes medications like GLP-1 receptor agonists on glaucoma progression.
-
#1
Bascom Palmer Eye Institute, University of Miami
Miami, FL
Bascom Palmer is consistently ranked as a top ophthalmology center with extensive clinical and translational research in glaucoma and neurodegenerative eye diseases, including studies on novel systemic therapies impacting ocular health.
-
#2
Massachusetts Eye and Ear Infirmary, Harvard Medical School
Boston, MA
Known for pioneering research in glaucoma pathophysiology and neuroprotection, with integrated programs studying systemic disease impacts on ocular neurodegeneration and innovative therapeutic approaches.
-
#3
Johns Hopkins Wilmer Eye Institute
Baltimore, MD
Wilmer Eye Institute has a strong history of glaucoma research and neurodegenerative disease studies, with ongoing investigations into systemic metabolic factors influencing optic nerve health.
-
#4
Mayo Clinic Department of Ophthalmology
Rochester, MN
Mayo Clinic integrates multidisciplinary research on glaucoma and systemic diseases, including metabolic and neurodegenerative mechanisms, contributing to understanding novel therapeutic impacts like GLP-1 receptor agonists.
-
#5
University of California, San Francisco (UCSF) Department of Ophthalmology
San Francisco, CA
UCSF is recognized for its innovative research in glaucoma and neurodegenerative ocular diseases, with active exploration of systemic metabolic therapies and their neuroprotective potential in glaucoma care.